Cargando…

Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood–Brain Barrier

The incidence of brain metastases has been increasing constantly for the last 20 years, because of better control of metastases outside the brain, and the failure of most drugs to cross the blood–brain barrier at relevant pharmacological concentrations. Recent advances in the molecular biology of ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angeli, Eurydice, Bousquet, Guilhem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468523/ https://www.ncbi.nlm.nih.gov/pubmed/34575525 http://dx.doi.org/10.3390/pharmaceutics13091446

Ejemplares similares

How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
por: Angeli, Eurydice, et al.
Publicado: (2019)

The Pharmacology of Xenobiotics after Intracerebro Spinal Fluid Administration: Implications for the Treatment of Brain Tumors
por: Paris, Justine, et al.
Publicado: (2021)

A Boom in Nanotechnologies for a High Level of Precision Medicine
por: Angeli, Eurydice, et al.
Publicado: (2023)

HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review
por: Gonullu, Burak, et al.
Publicado: (2023)

Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications
por: Nguyen, Thuy Thi, et al.
Publicado: (2023)

The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis
por: Perides, George, et al.
Publicado: (2006)

Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers?
por: Hamdan, Diaddin, et al.
Publicado: (2023)

How Soluble Fms-Like Tyrosine Kinase 1 Could Contribute to Blood-Brain Barrier Dysfunction in Preeclampsia?
por: Torres-Vergara, Pablo, et al.
Publicado: (2022)

Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE
por: Angeli, Eurydice, et al.
Publicado: (2020)

Facilitation of Drug Transport across the Blood–Brain Barrier with Ultrasound and Microbubbles
por: Meairs, Stephen
Publicado: (2015)

Combined action of EGFR tyrosine kinase inhibitors and whole-brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis
por: Lu, Yunyun, et al.
Publicado: (2016)

Treatment of transient prosopagnosia with a tyrosine kinase inhibitor in a case of brain metastasis from EGFR-mutated lung adenocarcinoma
por: Soyama, Shigeto, et al.
Publicado: (2022)

Brain Metastasis Mimicking Glioma on Imaging Appearance During Tyrosine Kinase Inhibitor Administration: A Case Series and Literature Review
por: Rai, Yurie, et al.
Publicado: (2023)

Brain-transportable dipeptides across the blood-brain barrier in mice
por: Tanaka, Mitsuru, et al.
Publicado: (2019)

BSCI-22. IDENTIFICATION OF ACTIONABLE TYROSINE KINASE-REGULATED NETWORKS REQUIRED FOR LUNG AND BREAST CANCER BRAIN METASTASIS
por: Pendergast, Ann Marie, et al.
Publicado: (2019)

Blood-Brain Barrier Integrity and Breast Cancer Metastasis to the Brain
por: Arshad, Farheen, et al.
Publicado: (2010)

The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies
por: Motaln, Helena, et al.
Publicado: (2023)

Passage of immunomodulators across the blood-brain barrier.
por: Stitt, J. T.
Publicado: (1990)

Passage of parasites across the blood-brain barrier
por: Masocha, Willias, et al.
Publicado: (2012)

RNAi Delivered across the Blood-Brain Barrier
Publicado: (2004)

RON tyrosine kinase mutations in brain metastases from lung cancer
por: Milan, Melissa, et al.
Publicado: (2018)

Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis
por: Zhang, Qiuyi, et al.
Publicado: (2016)

The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study
por: Choi, Jin-Hyuk, et al.
Publicado: (2022)

Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes
por: Kuo, Chia-Yu, et al.
Publicado: (2022)

Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier
por: Tashima, Toshihiko
Publicado: (2023)

Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors
por: Wang, Ting-Wei, et al.
Publicado: (2023)

Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018)

Transport of Amino Acids Across the Blood-Brain Barrier
por: Zaragozá, Rosa
Publicado: (2020)

The blood-brain barrier studied in vitro across species
por: Thomsen, Maj Schneider, et al.
Publicado: (2021)

How Glutamate Is Managed by the Blood–Brain Barrier
por: Hawkins, Richard A., et al.
Publicado: (2016)

Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases
por: Luo, Shuimei, et al.
Publicado: (2015)

Selective Permeabilization of the Blood–Brain Barrier at Sites of Metastasis
por: Connell, John J., et al.
Publicado: (2013)

Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors
por: Puputti, Marjut, et al.
Publicado: (2009)

Amelioration of age‐related brain function decline by Bruton's tyrosine kinase inhibition
por: Ekpenyong‐Akiba, Akang E., et al.
Publicado: (2019)

Regulation of brain endothelial cell physiology by the TAM receptor tyrosine kinase Mer
por: Happonen, Kaisa E., et al.
Publicado: (2023)

Bridging barriers: a comparative look at the blood–brain barrier across organisms
por: O'Brown, Natasha M., et al.
Publicado: (2018)

Frozen algorithms: how the brain's wiring facilitates learning
por: Raman, Dhruva V, et al.
Publicado: (2021)

Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on Lenvatinib
por: Decraecker, Marie, et al.
Publicado: (2021)

EGFR-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?
por: Cansouline, Xavier, et al.
Publicado: (2022)

Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation
por: Banks, William A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_udhemd1ahm2b1j516md09953p3